drugset / Trial / NCT00858013
Study of the Durability of Glycemic Control With Nateglinide
Phase 4
Completed
88 enrolled
Ajou University School of Medicine
Bundang CHA Hospital · collabHallym University Medical Center · collabHanyang University · collabInha University Hospital · collabKorea University Guro Hospital · collabKyunghee University Medical Center · collabMyongji Hospital · collabWonju Severance Christian Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This multi-center, randomized controlled study aims to evaluate the durability and efficacy of nateglinide therapy for long term glycemic control compared with glimepiride.
Timeline
- Start
- 2009-04-24
- Primary completion
- 2014-06-25
- Completion
- 2014-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glimepiride | Small molecule | 1 mg | — |
| Comparator | Glimepiride | Small molecule | 2 mg | — |
| Comparator | Nateglinide | Small molecule | 90 mg | — |
| Comparator | Nateglinide | Small molecule | 120 mg | — |